In the evolving landscape of diabetes management, novel medications like semaglutide and retatrutide are gaining traction. These agents, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist family, offer https://lexiesuyv500766.blogdal.com/39547565/semaglutide-vs-retatrutide-a-novel-comparison-in-diabetes-management